DAIC

JANUARY 11, 2024

In organ transplantation, an extended criteria donor is defined as having perceived risk factors linked to poor subsequent outcomes, for example, those with age >55 or ischemic times exceeding 4 hours, which sometimes leads to rejection of the donor organ. utilizing the Paragonix SherpaPak CTS (p=0.022).

Transplant 111

Transplant Heart Transplant Technology Risk Factors 111

Journal of Cardiothoracic Surgery

FEBRUARY 9, 2024

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

Congenital Heart Disease 52

Congenital Heart Disease Heart Transplant Transplant Congenital 52

HeartRhythm

AUGUST 21, 2024

Among pediatric patients undergoing orthotopic heart transplantation (OHT), 1-12% are reported to need a permanent pacemaker (PPM).1 1 There are limited studies on the outcomes of PPM placement, and the role of implantable cardioverter-defibrillator (ICD) in pediatric OHT remains unclear.

Heart Transplant 40

Heart Transplant Pediatrics Transplant Outcomes 40

Medical Xpress - Cardiology

FEBRUARY 12, 2024

Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. While the procedure offers hope, the long-term outcomes for these young patients remain suboptimal due to allograft rejection and graft failure.

Transplant 71

Transplant Pediatrics Heart Transplant Heart Failure 71

Frontiers in Cardiovascular Medicine

MAY 19, 2024

BackgroundThe use of Intra-aortic Balloon Pump (IABP) and Impella devices as a bridge to heart transplantation (HTx) has increased significantly in recent times. Out of them, 12% had primary outcomes indicating Status 2 failure. Our ML models were based on 19 variables from the UNOS data.

Heart Transplant 59

Heart Transplant Transplant BMI Aortic 59

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

Circulation: Heart Failure

APRIL 4, 2025

Circulation: Heart Failure, Ahead of Print. Heart failure is a global disease with significant morbidity. Heart transplant (HT) can be a lifesaving therapy for select patients with end-stage heart failure.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Article 40

Cardiology Update

APRIL 25, 2024

The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes. Among patients with HFpEF, those who received the shunt experienced poor outcomes than those who did not.

Heart Failure 98

Heart Failure Heart Transplant Transplant Research 98

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

Background Belt electrode skeletal muscle electrical stimulation (B-SES) is an emerging therapy anticipated to yield more favorable outcomes than conventional neuromuscular electrical stimulation (NMES), owing to its larger stimulation area. However, information on its efficacy and safety in patients with heart failure remains limited.

Heart Failure 124

Heart Failure Obesity Heart Transplant Transplant 124

DAIC

FEBRUARY 21, 2024

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Stroke Journal

JANUARY 30, 2025

Introduction:Pediatric heart transplant (PHT) recipient survival has improved. Yet, neurologic morbidity related to heart failure and its treatment persist. It can affect the functional outcome, increase risk of major adverse events, prolong LOS and increase the use of rehabilitation therapies (RT).

Heart Transplant 40

Heart Transplant Transplant Pediatrics Strokes 40

Journal of the American Heart Association

MARCH 8, 2024

The value of RVLSF in the assessment of RV systolic function in recipients of heart transplantation (HT) and whether RVLSF can replace strain parameters remains unknown.Methods and ResultsA total of 153 adult patients who underwent HT were consecutively enrolled in this prospective longitudinal study.

Heart Transplant 40

Heart Transplant Transplant Tricuspid Outcomes 40

HeartRhythm

SEPTEMBER 17, 2024

Urgent heart transplantation (HTx) may be considered when all previous strategies fail (1), albeit with substantial post-operative mortality (1). Although HTx is considered as a bail-out strategy, no data exist regarding outcomes of refractory ES patients listed for urgent HTx but ultimately not transplanted during the acute phase.

Transplant 40

Transplant Heart Transplant Ablation Outcomes 40

DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. 5 Kutty, S., et al (2016).

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

On the contrary, the use of transcatheter edge-to-edge mitral valve repair (TEER) has exponentially increased over the past decade, expanding its potential use even in patients on the heart transplantation waiting list.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure Heart Transplant Transplant 69

Circulation

NOVEMBER 11, 2024

Heart transplantation remains a vital treatment for end-stage heart failure, yet the scarcity of suitable donor hearts makes the treatment unavailable to many patients in critical need. Addressing this critical barrier could potentially improve post-transplant outcomes and make older donor hearts a viable option.

Transplant 40

Transplant Heart Transplant Heart Dysfunction Heart Failure 40

Circulation

FEBRUARY 26, 2024

Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assessment and management of cardiogenic shock in this high-risk and growing population are lacking.

Cardiogenic Shock 74

Cardiogenic Shock Best Practices Heart Transplant Transplant 74

The American Journal of Cardiology

JULY 6, 2024

Publication date: Available online 6 July 2024 Source: The American Journal of Cardiology Author(s): Jacob Agronin, Meredith Brown, Hannah Calvelli, Huaqing Zhao, Val Rakita, Yoshiya Toyoda, Mohammed Abul Kashem

Heart Transplant 40

Heart Transplant Transplant Outcomes 40

Circulation

NOVEMBER 11, 2024

Cox regression results showed that there is an increased risk of mortality in patients who did not receive transfusions before transplant (p<0.0001).Conclusion:While Cox regression results showed that there is an increased risk of mortality in patients who did not receive transfusions before transplant (p<0.0001).Conclusion:While

Transplant 40

Transplant Heart Transplant Risk Factors Outcomes 40

Open Heart

NOVEMBER 25, 2022

Cox models were created to investigate if UA was a significant predictor of adverse outcome where log1.1(UA) UA) was used to estimate the effect on outcome associated with a 10% increase in UA levels. Regression analyses were constructed to investigate the association between UA and haemodynamic variables.

Heart Failure 52

Heart Failure Outcomes Heart Transplant Artificial Heart 52

Circulation

NOVEMBER 11, 2024

Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020. Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients.

Cardiogenic Shock 40

Cardiogenic Shock Congenital Heart Disease Heart Failure Congenital 40

European Journal of Heart Failure

DECEMBER 13, 2023

Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. Abstract Aims There is uncertainty about the definition of iron deficiency (ID) and the association between ID and prognosis in patients with advanced heart failure. Non-scaled VENN diagram.

Heart Failure 40

Heart Failure Heart Transplant Transplant Tricuspid 40

Circulation

NOVEMBER 11, 2024

End-stage ischemic heart disease necessitates heart transplantation, and emerging cell therapy presents a promising solution to address donor scarcity. Disruption of gut microbiota significantly influences various diseases and treatments, including transplantation.

Ischemia 40

Ischemia Transplant Heart Transplant Biomarkers 40

Circulation: Heart Failure

MARCH 8, 2024

Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

European Journal of Heart Failure

NOVEMBER 9, 2023

However, data on long-term outcome after upgrade to CRT are scarce. The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation.

Outcomes 40

Outcomes Heart Failure Heart Transplant Defibrillator 40

Circulation

NOVEMBER 11, 2024

We collected demographic, pre-procedural, procedural, and outcome-related variables. The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001. were females.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Society of Thoracic Surgeons - Technology

JANUARY 19, 2022

With her fellowship, Dr. Fiedler plans to learn skills and administrative approaches that will help her expand the heart transplant program at UW-Madison, where she currently serves as associate director of heart transplantation and mechanical circulatory support.

Cardiothoracic 52

Cardiothoracic Heart Transplant Allied Health Education 52

European Journal of Heart Failure

NOVEMBER 19, 2024

The survey investigated four areas: guideline awareness, healthcare network organization, clinical case management, and perceptions of mechanical circulatory support (MCS) outcomes. Respondents were categorized into heart failure cardiologists (HFCs), general cardiologists (GCs), and other participants (OPs). of HFCs, 19.6%

Heart Failure 40

Heart Failure Transplant Heart Transplant Education 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Abstract Aims The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

Open Heart

MAY 25, 2022

Methods The primary outcome was the prevalence and incidence of TE in the patients with LVNC. The secondary outcome was the TE and mortality and heart transplantation rates between paediatric and adult patients with LVNC.

Heart Transplant 40

Heart Transplant Transplant Risk Factors Outcomes 40

Circulation: Heart Failure

JANUARY 16, 2025

However, no biomarker reflecting RVD is available for routine clinical use.METHODS:Proteomic analysis of myocardium from the left ventricle and right ventricle (RV) of patients with heart failure with reduced ejection fraction with (n=10) and without RVD (n=10) who underwent heart transplantation was performed. for both).

Biomarkers 40

Biomarkers Heart Failure Heart Transplant Transplant 40

Circulation

JANUARY 18, 2024

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) use to provide hemodynamic support for acute myocardial infarction has grown exponentially, is associated with poor outcomes, and is under active clinical investigation, yet the mechanistic effect of VA-ECMO on myocardial damage in acute myocardial infarction remains poorly understood.

Myocardial Infarction 45

Myocardial Infarction Heart Transplant Ischemia Transplant 45

MIBHS

SEPTEMBER 30, 2024

The fear of the unknown, of potential surgeries, and of long-term outcomes can be paralyzing. This fear can be compounded by the uncertainty surrounding the condition, as each CHD case is unique, and outcomes can vary widely. This involves opening the chest and heart to make the necessary repairs.

Congenital 52

Congenital Education Open-Heart Surgery Pediatrics 52

European Journal of Heart Failure

APRIL 13, 2025

The primary outcome was all-cause death and heart transplantation. Secondary heart failure (HF) and arrhythmic outcomes were also included. A total of 492 first degree relatives were enrolled. However, LV systolic dysfunction detected by FSP showed a better prognosis.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Electrocardiogram Transplant 40

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

Due to the extensive irreversible necrosis of myocardial cells caused by ischemia and hypoxia, these methods cannot reverse the damage, resulting in suboptimal long-term outcomes.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

American College of Cardiology

DECEMBER 4, 2024

For heart transplantation following donation after circulatory death (DCD HT), what are the short-term outcomes associated with organ procurement using a normothermic regional perfusion (NRP) strategy compared to a direct procurement and perfusion (DPP) strategy?

Heart Transplant 40

Heart Transplant Transplant Outcomes Article 40

DAIC

DECEMBER 8, 2023

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. milla1cf Fri, 12/08/2023 - 08:07 December 8, 2023 — Procyrion, Inc. ,

Technology 113

Technology Heart Failure Heart Transplant Transplant 113